The first 3 months after BCNU wafers implantation in high-grade glioma patients: Clinical and radiological considerations on a clinical series

Acta Neurochirurgica

Volumn 152, Issue 11, 2010, Pages 1923-1931

  Della Puppa, Alessandro ^a   Rossetto, Marta ^a   Ciccarino, Pietro ^a   Del Moro, Giulia ^a   Rotilio, Antonino ^a   Manara, Renzo ^a   Paola Gardiman, Marina ^a   Denaro, Luca ^a   D'Avella, Domenico ^a   Scienza, Renato ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Carmustine wafers; High grade gliomas; Safety; Surgical bed cyst

Indexed keywords

CARMUSTINE; CORTICOSTEROID; DEXAMETHASONE; TEMOZOLOMIDE; ALKYLATING AGENT;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG APPROVAL; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG IMPLANTATION; DRUG SAFETY; FEMALE; GLIOBLASTOMA; HOSPITAL DISCHARGE; HUMAN; INTRACRANIAL HYPERTENSION; ITALY; LOCAL THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RECURRENT CANCER; SURGICAL WARD; TUMOR BED CYST; WAFER; AGED; BRAIN TUMOR; CLINICAL TRIAL; GLIOMA; INFUSION PUMP; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; RADIOGRAPHY; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; FEMALE; GLIOMA; HUMANS; INFUSION PUMPS, IMPLANTABLE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 78149410228     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-010-0759-6     Document Type: Article

References (25)

1. Asher AL (2007) Prospective analysis of temozolomide as adjuvant to Gliadel and radiation in newly diagnosed malignant glioma. Abstract presented at the Annual Meeting of the American Association of Neurological Surgeons, Washington, DC, 2007
2. FJ Attenello D Mukherjee G Datoo MJ McGirt E Bohan JD Weingart A Olivi A Quinones-Hinojosa H Brem 2008 Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience Ann Surg Oncol 15 2887 2893 10.1245/s10434-008-0048-2 18636295
3. H Brem S Piantadosi PC Burger M Walker R Selker NA Vick K Black M Sisti S Brem G Mohr P Muller R Morawetz S Clifford Schold 1995 Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group Lancet 345 1008 1012 1:STN:280:DyaK2M3ktVansw%3D%3D 10.1016/S0140-6736(95)90755-6 7723496
4. Dal Pan G, Butler L, Schactman M (1997) Preliminary analysis of the GLIADEL treatment protocol. Abstract presented at the ASCO Annual Meeting, Atlanta, GA, 1997
5. BJ Darakchiev RE Albright JC Breneman RE Warnick 2008 Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme J Neurosurg 108 236 242 10.3171/JNS/2008/108/ 2/0236 18240917 (Pubitemid 351213285)
6. Eisai Inc. Gliadel Wafer: Heath Care Professionals. Available at: http://www.gliadel.com/docs/pdf/Gliadel-PI.pdf [Last accessed 2 February 2010]
7. HH Engelhard 2000 Tumor bed cyst formation after BCNU wafer implantation: report of two cases Surg Neurol 53 220 224 1:STN:280:DC%2BD3c3jsl2mtA%3D%3D 10.1016/S0090-3019(00)00162-2 10773252 (Pubitemid 30201525)
8. Engelhard HH, Maher de Leon ME, Rozental JM (1998) Tumor bed cyst formation after BCNU wafer implantation. Abstract presented at the Annual Meeting of the Congress of Neurological Surgeons, Seattle, WA, 1998
9. Giese A, Bock HC, Kantelhardt SR, Rohde V (2010) Risk management in the treatment of malignant gliomas with BCNU wafer implants. Cent Eur Neurosurg Jan 8 doi: 10.1055/s-0029-1242775
10. D González Vidal 2006 The safety of Gliadel implants during the indication period in recurrent surgery in the treatment of glioblastoma multiforme [abstract] NeurocirugIa 17 77 78
11. S Gururangan L Cokgor JN Rich S Edwards ML Affronti JA Quinn JE Herndon 2nd JM Provenzale RE McLendon S Tourt-Uhlig JH Sampson V Stafford-Fox S Zaknoen M Early AH Friedman HS Friedman 2001 Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas Neuro-Oncology 3 246 250 1:CAS:528:DC%2BD38Xks1Olsrs%3D 11584894
12. LR Kleinberg J Weingart P Burger CK Grossman Li K SA A Olivi MD Wharam H Brem 2004 Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management Cancer Invest 22 1 9 10.1081/CNV-120027575 15069758
13. R LaRocca S Glisson J Hargis D Petruska W Villanueva D Morassutti D Horne F Amin-Zimmerman 2005 High-grade glioma treated with surgery; carmustine wafer; postoperative radiation; and procarbazine, lomustine, and vincristine chemotherapy Neurosurg Q 15 167 171 10.1097/01.wnq.0000174599.99440.68 (Pubitemid 41279345)
14. MJ McGirt AT Villavicencio KR Bulsara HS Friedman AH Friedman 2002 Management of tumor bed cysts after chemotherapeutic wafer implantation. report of four cases J Neurosurg 96 941 945 10.3171/jns.2002.96.5.0941 12005403
15. MJ McGirt KD Than JD Weingart KL Chaichana FJ Attenello A Olivi J Laterra LR Kleinberg SA Grossman H Brem A Quiñones-Hinojosa 2009 Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme J Neurosurg 110 3 583 588 1:CAS:528:DC%2BD1MXjvVyns7g%3D 10.3171/2008.5.17557 19046047
16. PC McGovern E Lautenbach PJ Brennan RA Lustig NO Fishman 2003 Risk factors for post-craniotomy surgical site infection after 1, 3-bis(2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement Clin Infect Dis 36 759 765 1:CAS:528:DC%2BD3sXjtVKqtbc%3D 10.1086/368082 12627360 (Pubitemid 36337980)
17. NCCN (2009) NCCN guidelines. Available at: http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp [Last accessed 2 February 2010]
18. E Pan SB Mitchell JS Tsai 2008 A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients J Neuro-oncol 88 353 357 10.1007/s11060-008-9576-7
19. Sabel M, Giese A (2008) Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. Curr Med Res Opin. 2008 Oct 20. doi: 10.1185/03007990802508180
20. BR Subach TF Witham D Kondziolka LD Lunsford M Bozik D Schiff 1999 Morbidity and survival after 1, 3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case matched cohort series Neurosurgery 45 17 22 1:STN:280:DyaK1MzktFGisw%3D%3D 10.1097/00006123- 199907000-00004 10414561 (Pubitemid 29318869)
21. Tait MJ, Critchley GR (2006) Experience of revision craniotomy for debulking of high grade gliomas in 27 patients in a single UK centre, with and without insertion of carmustine wafers. Meeting of the Society of British Neurosurgeons, Preston, UK, 2006
22. Uff CEG, Bradford R (2005) Use of Gliadel (BCNU) Wafers in high grade glioma. Abstract presented at the meeting of the Society of British Neurosurgeons, Plymouth, UK, 2005
23. D Volc K Jellinger H Flament F Böck J Klumair 1981 Cerebral space-occupying cysts following radiation and chemotherapy of malignant gliomas Acta Neurochir (Wien) 57 177 193 1:STN:280:DyaL38%2FitVGqsg%3D%3D 10.1007/BF01664836 (Pubitemid 11006135)
24. J Weingart SA Grossman KA Carson JD Fisher SM Delaney ML Rosenblum A Olivi K Judy SB Tatter ME Dolan 2007 Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial J Clin Oncol 25 399 404 1:CAS:528:DC%2BD2sXisFykur0%3D 10.1200/JCO.2006.06.6290 17264335 (Pubitemid 350002988)
25. M Westphal DC Hilt E Bortey P Delavault R Olivares PC Warnke IR Whittle J Jääskeläinen Z Ram 2003 A Phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-Oncology 5 79 88 1:CAS:528:DC%2BD3sXjtVKltL4%3D 12672279